Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The metric has seen a significant loss of -3.95% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 6.05%. Over the past 30 days, the price of TEVA has fallen by 3.55%. And in the last five days, it has fallen by -0.11%.
The stock of Teva- Pharmaceutical Industries Ltd. ADR (TEVA) is currently priced at $8.76. In the last session, the stock climbed significantly, topping out at $8.955 after opening at $8.91. The day’s lowest price was $8.64 before the stock closed at $8.96.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Teva- Pharmaceutical Industries Ltd. ADR experienced a rather shaky stock market performance. The highest value in the past year was recorded at $11.44 on 01/12/23 and the lowest value was $7.09 on 05/31/23.
52-week price history of TEVA Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Teva- Pharmaceutical Industries Ltd. ADR’s current trading price is -23.46% away from its 52-week high, while its distance from the 52-week low is 23.64%. The stock’s price range during this period has varied between$7.09 and $11.44. The Teva- Pharmaceutical Industries Ltd. ADR’s shares, which operate in the Healthcare, saw a trading volume of around 7.22 million for the day, a figure considerably lower than their average daily volume of 8.36 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) has experienced a quarterly decline of -8.37% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 9.82B and boasts a workforce of 36826 employees.
Teva- Pharmaceutical Industries Ltd. ADR: Analysts’ Ratings Unveiled
As of right now, 3 analysts are rating Teva- Pharmaceutical Industries Ltd. ADR as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 7 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 2 analysts are rating the stock as SELL.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 9.08, with a change in price of +1.12. Similarly, Teva- Pharmaceutical Industries Ltd. ADR recorded 9,178,401 in trading volume during the last 100 days, posting a change of +14.66%.
TEVA’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for TEVA stands at 2.93. Similarly, the long-term debt-to-equity ratio is also 2.72.
TEVA Stock Stochastic Average
As of today, Teva- Pharmaceutical Industries Ltd. ADR’s raw stochastic average for the last 50 days stands at 26.45%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 46.55%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 54.25% and 53.08%, respectively.
